Cimetidine's pharmacogenetic interactions involve the cytochrome P450 system enzymes CYP2C19, CYP2D6, and CYP3A4, as well as the ABCB1 transporter gene, which can significantly affect its metabolism, distribution, and elimination. These genetic variations influence how different individuals respond to the drug, impacting its effectiveness and potential side effects by altering the drug's concentration profiles in the body.